Tag: presentation of risk information

CHC-offLabel2

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

CHC_general1

OPDP Focuses on Misleading Opioid Claims Amid National Crisis

CHC_DTCadvertisement2

Citizen Petition Says Music in DTC Ads Distracts from Risk Info, Calls for FDA Ban

CHC_FDA-Regulatory Images1

OPDP Cites Risk Presentation Issues in YouTube Video, Email in New Enforcement Letters

News Aikin

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

CHC_FDA-Regulatory Images1

OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug